American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3847)
  2. Hematologic Malignancies, Division of (3642)
  3. Center for Hematologic Malignancies (3544)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1290)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (936)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (899)
  10. Tow Center for Developmental Oncology (TCDO) (863)
Search Within
Formats
  1. Meeting Abstract (3939)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3847)
  2. Hematologic Malignancies, Division of (3642)
  3. Center for Hematologic Malignancies (3544)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1290)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (328)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (292)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (217)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (4954)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5326)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An integrative genomics approach uncovers the basis of resistance to AZA therapy in MDS and CMML
    Meeting Abstract

    Unnikrishnan, A.; Papaemmanuil, E.; Beck, D.; Verma, A.; Kumari, A.; Richards, L. A.; Knezevic, K.; Chandrakanthan, V.; Thoms, J. A. I.; Tursky, M. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Outcomes in diffuse large B-cell lymphoma (DLBCL) patients relapsing after autologous stem cell transplantation (ASCT): An analysis of patients included in the CORAL study
    Meeting Abstract

    Van Den Neste, E.; Schmitz, N.; Mounier, N.; Gill, D.; Trneny, M.; Milpied, N.; Radford, J. A.; Ketterer, N.; Shpilberg, O.; Duhrsen, U.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A clinicogenetic risk model (m7-FLIPI) prospectively identifies one-half of patients with early disease progression of follicular lymphoma after first-line immunochemotherapy
    Meeting Abstract

    Vindi, J.; Kridel, R.; Staiger, A. M.; Szczepanowski, M.; Horn, H.; Dreyling, M. H.; Rosenwald, A.; Ott, G.; Klapper, W.; Zelenetz, A. D.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis
    Meeting Abstract

    Viny, A. D.; Ott, C. J.; Spitzer, B.; Rivas, M. A.; Meydan, C.; Papalexi, E.; Yelin, D.; Shank, K.; Reyes, J.; Chiu, A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Alliance A061202. A phase I/II study of pomalidomide, dexamethasone and ixazomib versus pomalidomide and dexamethasone for patients with multiple myeloma refractory to lenalidomide and proteasome inhibitor based therapy: Phase I results
    Meeting Abstract

    Voorhees, P. M.; Mulkey, F.; Hassoun, H.; Paba-Prada, C. E.; Efebera, Y. A.; Hoke, E.; Aquino, G.; Carlisle, D.; Suman, V.; Richardson, P. G.
    Blood (2015)

    Fulltext@MSK | Save
  • From T-cell engineering to CAR therapy: Progress and prospects
    Meeting Abstract

    Sadelain, M.
    Blood (2015)

    Fulltext@MSK | Save
  • Marqibo®, vincristine sulfate liposome injection, for the treatment of advanced, relapsed or refractory Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in an adolescent young adult (AYA) population
    Meeting Abstract

    Schiller, G. J.; Damon, L. E.; Stock, W.; Coutre, S. E.; Hsu, P.; Prasad, L.; Douer, D.
    Blood (2015)

    Fulltext@MSK | Save
  • Results of a phase III randomized, multi-center study of allogeneic stem cell transplantation after high versus reduced intensity conditioning in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901
    Meeting Abstract

    Scott, B. L.; Pasquini, M. C.; Logan, B.; Wu, J.; Devine, S.; Porter, D. L.; Maziarz, R. T.; Warlick, E.; Fernandez, H. F.; Alyea, E. P.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A prognostic system predictive of outcomes in persons undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome
    Meeting Abstract

    Shaffer, B. C.; Ahn, K. W.; Hu, Z. H.; Popat, U. R.; Kalaycio, M.; Maziarz, R. T.; Alyea, E.; Sobecks, R. M.; Pavletic, S. Z.; Tallman, M. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Bantilan, K. S.; Verwys, S. L.; McCall, S. J.; Yahalom, J.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save